Buntanetap

DB15317InvestigationalSmall molecule

Buntanetap (previously known as Posiphen) is under investigation in clinical trial NCT02925650 (Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease).

Chemical structure of Buntanetap
Formula / weight
C20H23N3O2 · 337.423 g/mol (avg)
Also known as
(+)-Posiphen · Posiphen
Code names
ANVS-401 · ANVS-405

Resolves to

Compound
UNIIZ0O4TJ588OCAS116839-68-0ChEMBLCHEMBL4297417
Structure
InChIKeyPBHFNBQPZCRWQP-ICSRJNTNSA-NSMILES[H][C@@]12N(C)CC[C@@]1(C)C1=C(C=CC(O\C(O)=N\C3=CC=CC=C3)=C1)N2C
Targets
P22303ACHE

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
292Drug interactionsStructured to mechanism, not free text
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Buntanetap, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In